About Us
Overview
Mission and Vision
Board of Directors
Recognitions
Business Areas
Overview
India - Branded Generics
Emerging Markets - Branded Generics
USA - Generics
Africa - Institution Business
Manufacturing
Overview
Manufacturing facilities
Quality
Environment, Health & Safety
R & D
Investors
Financials
Corporate Governance
Investor Information
Media
Press release
Media Covarage
Media Kit
Career
Life at Ajanta
Work with us
CSR
Contact Us
Search
investor information
Home
Investors
Investor Information
Statutory Communications
Year
2024-25
2023-24
2022-23
2021-22
2020-21
2019-20
2018-19
2017-18
2016-17
2015-16
AGM proceedings for SEs
Intimation of Schedule of Analyst Meeting
US FDA inspection of Dahej facility
Press Release
<
7
8
9
Related Links
Statutory Communications
Unclaimed Dividend
Unclaimed Shares
Investor Contact
Smart ODR & KYC form
FAQs
Buyback
Miscellaneous
